Zoetis Q4 Profit Results Beat View; Lowers 2015 Revenue Outlook - Quick Facts

(RTTNews) - Zoetis Inc. (ZTS), the former animal health business of Pfizer Inc. (PFE), reported that its net income for the fourth quarter increased to $126 million or $0.25 per share from $105 million or $0.21 per share in the prior-year period.

The latest quarter's results include the net impact of $77 million or $0.15 per share for purchase accounting adjustments, acquisition-related costs and certain significant items.

Adjusted net income for the quarter was $203 million or $0.40 per share, compared to $180 million or $0.36 per share last year. On average, thirteen analysts polled by Thomson Reuters expected the company to report earnings of $0.36 per share for the quarter. Analysts' estimates typically exclude special items.

Revenue for the quarter rose 5 percent to $1.32 billion from $1.25 billion in the year ago quarter. Analysts had a consensus revenue estimate of $1.27 billion.

Looking ahead to fiscal 2015, Zoetis now expects reported earnings of $1.32 to $1.39 per share, adjusted earnings of $1.61 to $1.68 per share, and revenues in a range of $4.800 billion to $4.900 billion.

Earlier, the company forecast full-year reported earnings of $1.36 to $1.43 per share, adjusted earnings of $1.61 to $1.68 per share, and revenues in a range of $4.850 billion to $4.950 billion.

Wall Street currently is looking for fiscal year 2015 earnings of $1.65 per share on revenues of $4.91 billion.